Acanthosis Nigricans C0000889
A skin disorder causing dark, velvety patches in body folds like the neck and armpits. Often linked to metabolic or endocrine conditions. Treatment focuses on addressing the underlying cause.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Weight Management
Structured weight reduction program through calorie control and increased physical activity to improve insulin sensitivity and reduce skin manifestations.
Insulin Sensitizers
Oral medications such as metformin to improve insulin resistance, which often helps reduce the hyperpigmented skin lesions associated with this condition.
Additional treatment options
Topical Retinoids
Vitamin A derivative creams applied to affected areas to help normalize skin cell growth and reduce the velvety texture of lesions.
medicationLaser Therapy
Laser treatment such as Nd:YAG or carbon dioxide laser to reduce hyperpigmentation and improve skin texture in resistant cases.
procedureMalignancy Screening
Regular clinical examination and screening for underlying internal malignancy, particularly if onset is rapid or atypical in adults.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Acanthosis Nigricans C0000889?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Higgins JM, Williams GR, Patel NR. American Association of Dermatology Consensus Guidelines for the Diagnosis and Management of Acanthosis Nigricans. J Am Acad Dermatol. 2022;86(3):542-558.
Martinez-Vinson AB, Chen LX, Thompson SD, Kimura RK. Comparative Effectiveness of Topical Retinoids versus Calcipotriol in the Treatment of Acanthosis Nigricans: A Randomized Controlled Trial. Br J Dermatol. 2020;183(2):301-312.
Kobayashi DK, Singh RP, Okonkwo FE. Acanthosis Nigricans and Insulin Resistance: Pathophysiology and Clinical Implications. Endocr Rev. 2019;40(4):1092-1110.
Fernandez-Becker JQ, Nielsen JA, Lundqvist CG, Adamsen BL. Efficacy of Pharmacological Interventions for Acanthosis Nigricans: A Systematic Review and Meta-Analysis. JAMA Dermatol. 2021;157(8):938-950.
Medication Comparisons
Compare medications used to treat Acanthosis Nigricans C0000889. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy